Ella Reich

Ella Reich is a Ph.D. candidate in Pr. Laurence Zitvogel’s ‘Tumour Immunology and Anti-Cancer Immunotherapy’ laboratory. She completed her degree in Biomedical Engineering at Imperial College London (United Kingdom) before pursuing a master’s in Biotechnology at the University of Queensland (Australia). Her master’s thesis, conducted in collaboration with the biotechnology company Microba Life Sciences, focused on the production of key metabolites by their live biotherapeutics candidate for treating inflammatory bowel disease. Passionate about the microbiome and its role in resistance to immunotherapies, she is now researching therapeutic approaches to mitigate the harmful effects of gut dysbiosis in cancer patients.